Serum tissue inhibitor of metalloproteinases-1 and higher risk features of coronary plaque. A volumetric multivessel intravascular ultrasound study

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages

  Kruk, Mariusz ^a   Kalińczuk, Łukasz ^a   Pregowski, Jerzy ^a   Przyłuski, Jakub ^a   Janas, Jadwiga ^a   Chmielak, Zbigniew ^a   Demkow, Marcin ^a   Debski, Artur ^a   Ciszewski, Andrzej ^a   Otto, Bozena ^a   Witkowski, Adam ^a   Ruzyłło, Witold ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Atherosclerosis; Coronary disease; Extracellular matrix

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; GELATINASE A; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MATRILYSIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; MEDICAL ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE SIZE; STABLE ANGINA PECTORIS;

ANGINA PECTORIS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CALCINOSIS; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES, SECRETED; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 34848875375     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.08.045     Document Type: Article

References (35)

1. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient A call for new definitions and risk assessment strategies. Part I. Circulation 108 (2003) 1664-1672
2. Kotani J., Mintz G.S., Castagna M.T., et al. Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction. Circulation 107 (2003) 2889-2893
3. Little W.C., Constantinescu M., Applegate R.J., et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?. Circulation 78 (1988) 1157-1166
4. Tinana A., Mintz G.S., and Weissman N.J. Volumetric intravascular ultrasound quantification of the amount of atherosclerosis and calcium in nonstenotic arterial segments. Am J Cardiol 89 (2002) 757-760
5. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodelling and atherogenesis: the good, the bad, and the ugly. Circ Res 90 (2002) 251-262
6. Vincenti M.P. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol Biol 151 (2001) 121-148
7. Lubos E., Schnabel R., Rupprecht H.J., et al. Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study. Eur Heart J 27 (2006) 150-156
8. Tayebjee M.H., Lip G.Y.H., Tan K.T., et al. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. Am J Cardiol 96 (2005) 339-345
9. Inokubo Y., Hanada H., Ishizaka H., et al. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 141 (2001) 211-217
10. Di Mario C., Gorge G., Peters R., et al. Clinical application and image interpretation in intracoronary ultrasound. Study group on intracoronary imaging of the working group of coronary circulation and of the subgroup on intravascular ultrasound of the working group of echocardiography of the European Society of Cardiology. Eur Heart J 19 (1998) 207-229
11. Tuzcu E.M., Berkalp B., De Franco A.C., et al. The dilemma of diagnosing coronary calcification: angiography versus intravascular ultrasound. J Am Coll Cardiol 27 (1996) 832-838
12. Pregowski J., Tyczynski P., Mintz G.S., et al. Incidence and clinical correlates of ruptured plaques in Saphenous vein grafts: an intravascular ultrasound study. J Am Coll Cardiol 45 (2005) 1974-1979
13. Schoenhagen P., Ziada K.M., Kapadia S.R., Crowe T.D., Nissen S.E., and Tuzcu E.M. Extent and direction of arterial remodelling in stable and unstable coronary syndromes. Circulation 101 (2000) 598-603
14. Nakamura M., Nishikawa H., Mukai S., et al. Impact of coronary artery remodelling on clinical presentation of coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol 37 (2001) 63-69
15. von Birgelen C., Klinkhart W., Mintz G.S., et al. Plaque distribution and vascular remodelling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. J Am Coll Cardiol 37 (2001) 1864-1870
16. Yamagishi M., Terashima M., Awano K., et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol 35 (2000) 106-111
17. Erbel R., and Schmermund A. Clinical significance of coronary calcification arterioscler. Thromb Vasc Biol 24 (2004) e172
18. Schoenhagen P., and Nissen S.E. Coronary atherosclerotic disease burden: an emerging endpoint in progression/regression studies using intravascular ultrasound current drug targets. Cardiovasc Hematol Disord 3 (2003) 218-226
19. Abizaid A.S., Mintz G.S., Abizaid A., et al. One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms. J Am Coll Cardiol 34 (1999) 707-715
20. Rioufol G., Finet G., Ginon I., et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 106 (2002) 804-808
21. Raggi P., Taylor A., Fayad Z., et al. Atherosclerotic plaque imaging. Arch Intern Med 165 (2005) 2345-2353
22. Nissen S.E. Identifying patients at risk: novel diagnostic techniques. Eur Heart J Suppl 6 (2004) 15-20
23. Elmore J.R., Keister B.F., Franklin D.P., Youkey J.R., and Carey D.J. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Ann Vasc Surg 12 (1998) 221-228
24. Knox J.B., Sukhova G.K., Whittemore A.D., and Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95 (1997) 205-212
25. Galis Z.S. Vulnerable plaque. Circulation 110 (2004) 244-246
26. Silence J., Collen D., and Lijnen H.R. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ Res 90 (2002) 897-903
27. Chen F., Eriksson P., Hansson G.K., et al. Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque. Int J Mol Med 15 (2005) 57-65
28. Beaudeux J.L., Giral P., Bruckert E., et al. Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia. Atherosclerosis 169 (2003) 139-146
29. Zureik M., Beaudeux J.-L., Courbon D., and Benetos A. Ducimetiere P Serum tissue inhibitors of metalloproteinases 1 (TIMP-1) and carotid atherosclerosis and aortic arterial stiffness. J Hypertens 23 12 (2005) 2263-2268
30. Noji Y., Kajinami K., Kawashiri M.A., et al. Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin Chem Lab Med 39 (2001) 380-384
31. Sundstrom J., Evans J.C., Benjamin E.J., et al. Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study. Eur Heart J 25 (2004) 1509-1516
32. Boström K. Proinflammatory vascular calcification. Circ Res 96 (2005) 1219-1220
33. Kieffer P., Giummelly P., Schjoth B., et al. Activation of metalloproteinase-2, loss of matrix scleroprotein content and coronary artery calcification. Atherosclerosis 157 (2001) 251-254
34. Basalyga D.M., Simionescu D.T., Xiong W., et al. Elastin degradation and calcification in an abdominal aorta injury model. Circulation 110 (2004) 3480-3487
35. Kaden J.J., Vocke D.C., Fischer C.S., et al. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis. Z Kardiol 93 (2004) 124-130